Mankind Pharma fundamental analysis
MANKIND
2213.9
10.40 (-0.47%)Last updated on 13 Jan, 2026 | 15:40 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Mankind Pharma Fundamentals
P/E Ratio
51.86
P/B Ratio
5.94
Div. Yield
0
Sector P/E
69.98
Sector P/B
0.94
Sec. Div. Yield
0.57
Mankind Pharma Fundamentals is currently trading with a P/E Ratio of 51.86, compared to the sector average of 69.98. Its P/B Ratio stands at 5.94, while the sector’s is 0.94. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Mankind Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Mankind Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
